United States· US:60505-4755_93fc1c54-8f73-3dcb-033f-4cd9411875ff
Clorazepate Dipotassium
A medicinal product containing clorazepate dipotassium, registered in United States by Apotex Corp..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CLORAZEPATE DIPOTASSIUM
- Manufacturer
- Apotex Corp.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1160505-4755-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Clorazepate dipotassium in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTranxene 10 mgNeuraxpharm Belgium
- SpainCLORAZEPATO NORMON 10 mg CAPSULAS DURAS EFGLaboratorios Normon S.A.
- CanadaCLORAZEPATEAA PHARMA INC
- GermanyTranxiliumNeuraxpharm Arzneimittel Gmbh
- FinlandAnxidinOrion Corporation Orion Pharma
- United KingdomTranxene 15mg capsulesBoehringer Ingelheim Ltd
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Tranxene, Uni-Tranxene
- Germany · Tranxilium, Tranxilium Tabs
- Spain · Clorazepato Normon, Tranxilium
- France · Tranxene
- Greece · Tranxene
- Italy · Transene
- Lithuania · Tranxene
- Luxembourg · Tranxene, Uni-Tranxene
- Netherlands · Tranxène, Tranxène Mb
- Poland · Cloranxen, Tranxene
- Portugal · Medipax, Tranxene
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4243302-aee7-40d4-af09-ec242b46d606 GET /v1/drugs/f4243302-aee7-40d4-af09-ec242b46d606?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "7.5",
"substance": "CLORAZEPATE DIPOTASSIUM",
"productndc": "60505-4755",
"dosage_form": "TABLET",
"dea_schedule": "CIV",
"strength_unit": "mg/mg",
"application_number": "ANDA215566",
"marketing_category": "ANDA"
}See everything about clorazepate dipotassium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.